Viking Global Investors
MRNA icon

Viking Global Investors’s Moderna MRNA Stock Holding History

Viking Global Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-994,886
Closed -$29.8M – 82
2020
Q1 		$29.8M Sell
994,886
-2,326,869
-70% -$53.5M 0.16% 56
2019
Q4 		$65M Sell
3,321,755
-1,356,026
-29% -$24.1M 0.3% 51
2019
Q3 		$74.5M Sell
4,677,781
-3,519,677
-43% -$52M 0.39% 42
2019
Q2 		$120M Sell
8,197,458
-8,470,408
-51% -$182M 0.54% 38
2019
Q1 		$339M Sell
16,667,866
-413,298
-2% -$7.67M 1.95% 20
2018
Q4 		$261M Buy
+17,081,164
New +$281M 1.48% 20

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Viking Global Investors's MRNA Position: Q2 2020 in Review

Viking Global Investors sold out of Moderna (MRNA) in Q2 2020, closing a stake of 994,886 shares — an estimated $29.8M sold.

Viking Global Investors first reported a position in MRNA in Q4 2018 and held it in 6 quarters. The position peaked at $339M in Q1 2019. 489 funds tracked by Wall St. Rank hold MRNA as of Q2 2020.

  • Viking Global Investors reported no remaining Moderna position as of Q2 2020 after selling out during the quarter.
  • Viking Global Investors sold 994,886 Moderna shares in Q2 2020, an estimated $29.8M.
  • Viking Global Investors first reported a position in Moderna in Q4 2018 and held it in 6 quarters.
  • Viking Global Investors's Moderna position peaked at $339M in Q1 2019.
  • 489 funds tracked by Wall St. Rank held Moderna as of Q2 2020.

Based on Viking Global Investors's 13F filing for Q2 2020, filed 7 Aug 2020.